Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm
NCT01117844
Proton Radiation For Meningiomas and Hemangiopericytomas
Feasibility and Phase II Study Using Proton Radiation For WHO Grade I-III Meningiomas and Hemangiopericytomas
Sponsor: Abramson Cancer Center at Penn Medicine
Conditions
Hemangiopericytoma Meningioma
Interventions
Proton Radiation
Last updated: Nov 6, 2024 Started: Feb 4, 2010 Primary completion: Mar 31, 2023 Completion: Mar 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT01117844, this PHASE1/PHASE2 trial focuses on Hemangiopericytoma and Meningioma and remains completed. Sponsored by Abramson Cancer Center at Penn Medicine, it has been updated 0 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
No change history available.
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Abramson Cancer Center at Penn Medicine
Data source: Abramson Cancer Center at Penn Medicine
For direct contact, visit the study record on ClinicalTrials.gov .